Tyler Van Buren, an analyst from TD Cowen, maintained the Buy rating on Immunocore Holdings. The associated price target is $60.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tyler Van Buren’s rating is based on a comprehensive analysis following Immunocore’s third-quarter earnings report. Despite a minor adjustment in the revenue forecast for Kimmtrak in 2025, the overall outlook remains positive, with a projected revenue of $405 million.
The decision to maintain a Buy rating and a DCF-based price target of $60 per share reflects confidence in the company’s financial health and future growth potential. These factors indicate a favorable investment opportunity, justifying the Buy recommendation.
In another report released on November 10, H.C. Wainwright also reiterated a Buy rating on the stock with a $100.00 price target.